-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Myeloid Malignancies

Symposia: Scientific Workshop on Myeloid Development Program: Scientific Workshops
Friday, December 8, 2023: 3:33 PM-4:15 PM
Room 6CF (San Diego Convention Center)
Moderator:
and Zuzana Tothova, MD, PhD, Dana-Farber Cancer Institute
Disclosures:
No relevant conflicts of interest to declare.
Moderator Introduction

Zuzana Tothova, MD, PhD

Dana-Farber Cancer Institute, Boston, MA
Elevated Functional Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of Granulocyte – Colony Stimulating Factor Mobilized Dnmt3a-Mutant Mice

Jennifer J. Trowbridge, PhD

The Jackson Laboratory, Bar Harbor, ME
Q+A

Jennifer J. Trowbridge, PhD

The Jackson Laboratory, Bar Harbor, ME
Early Steps of ETO2-GLIS2 Leukemogenesis Using Novel Human Cell-Based Models

Thomas Mercher, PhD

Institut Gustave Roussy, Villejuif, France
Q+A

Thomas Mercher, PhD

Institut Gustave Roussy, Villejuif, France
A Novel Bone Marrow Failure Mutation Results in Altered Taspase1 Substrate Specificity

Craig M Forester, MD, PhD

Children's Hospital of Colorado, Aurora, CO
Q+A

Craig M Forester, MD, PhD

Children's Hospital of Colorado, Aurora, CO
Igf2bp1 Is Essential for Eto2/Glis2 Leukemogenesis Via Stabilization of Primitive Hematopoietic Transcriptional Programs

Lynn H Lee, MD

Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Q+A

Lynn H Lee, MD

Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
See more of: Scientific Workshop on Myeloid Development
See more of: Scientific Workshops
<< Previous Session | Next Session >>